• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中等收入国家高血压相关的流行病学和经济负担挑战:来自墨西哥的证据。

Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.

作者信息

Arredondo Armando, Cuadra Silvia Magali, Duarte Maria Beatriz

机构信息

National Institute of Public Health-Mexico, School of Public Health, University of Montreal, Cuernavaca, QC, H3T 1 J4, Mexico.

National Institute of Public Health, Av Universidad 655, CP 62508, Cuernavaca, Mexico.

出版信息

BMC Public Health. 2015 Nov 6;15:1106. doi: 10.1186/s12889-015-2430-x.

DOI:10.1186/s12889-015-2430-x
PMID:26546356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4636741/
Abstract

BACKGROUND

In order to identify the challenges resulting from hypertension in a middle income country, this study has developed probabilistic models to determine the epidemiological and economic burden of hypertension in Mexico.

METHODS

Considering a population base of 654,701 reported cases of adults with hypertension, we conducted a longitudinal analyses in order to identify the challenges of epidemiological changes and health care costs for hypertension in the Mexican health system. The cost-evaluation method used was based on the instrumentation technique. To estimate the epidemiological changes for 2015-2017, probabilistic models were constructed according to the Box-Jenkins technique.

RESULTS

Regarding changes in expected cases for 2015 vs. 2017, an increase of 12 % is expected (p < 0.001). Comparing the economic impact in 2015 versus 2017 (p < 0.001), there is a 23 % increase in financial requirements. The total amount for hypertension in 2016 (US dollars) will be $6306,685,320 Of these, $ 2990,109,035 will be as direct costs and $ 3316,576,285 as indirect costs.

CONCLUSIONS

If the risk factors and care models remain as they are currently in the health system, the financial consequences will have a major impact on the out-of-pocket users, following in order of importance, on social security providers and on public assistance providers.

摘要

背景

为了确定中等收入国家高血压带来的挑战,本研究建立了概率模型,以确定墨西哥高血压的流行病学和经济负担。

方法

考虑到654701例报告的成年高血压患者的人群基数,我们进行了纵向分析,以确定墨西哥卫生系统中高血压的流行病学变化和医疗保健成本方面的挑战。所采用的成本评估方法基于工具技术。为了估计2015 - 2017年的流行病学变化,根据Box - Jenkins技术构建了概率模型。

结果

关于2015年与2017年预期病例的变化,预计增加12%(p < 0.001)。比较2015年与2017年的经济影响(p < 0.001),资金需求增加了23%。2016年高血压的总费用(美元)将为6306685320美元。其中,2990109035美元为直接成本,3316576285美元为间接成本。

结论

如果卫生系统中的风险因素和护理模式保持现状,财务后果将对自费患者产生重大影响,其次按重要性顺序是对社会保障提供者和公共援助提供者产生影响。

相似文献

1
Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.中等收入国家高血压相关的流行病学和经济负担挑战:来自墨西哥的证据。
BMC Public Health. 2015 Nov 6;15:1106. doi: 10.1186/s12889-015-2430-x.
2
Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.墨西哥老年人高血压的流行病学和财务指标:拉丁美洲卫生规划与管理面临的挑战
Int J Health Plann Manage. 2017 Apr;32(2):e121-e136. doi: 10.1002/hpm.2362. Epub 2016 May 30.
3
Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.慢性病的成本与流行病学变化:对卫生系统的影响与挑战
PLoS One. 2015 Mar 17;10(3):e0118611. doi: 10.1371/journal.pone.0118611. eCollection 2015.
4
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico.拉丁美洲高血压的流行病学变化及其经济后果:对墨西哥卫生系统和患者的影响。
Cad Saude Publica. 2012 Mar;28(3):497-502. doi: 10.1590/s0102-311x2012000300010.
5
Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.拉丁美洲慢性病流行变化的医疗保健成本及财务后果:来自墨西哥的证据。
Public Health. 2005 Aug;119(8):711-20. doi: 10.1016/j.puhe.2005.01.009.
6
Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.拉丁美洲高血压的流行病学变化与经济负担:来自墨西哥的证据
Am J Hypertens. 2006 Jun;19(6):553-9. doi: 10.1016/j.amjhyper.2005.10.028.
7
Health disparities from economic burden of diabetes in middle-income countries: evidence from México.中低收入国家糖尿病经济负担导致的健康差距:来自墨西哥的证据。
PLoS One. 2013 Jul 12;8(7):e68443. doi: 10.1371/journal.pone.0068443. Print 2013.
8
Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.墨西哥糖尿病和高血压的流行病学及经济负担面临的挑战。
Rev Saude Publica. 2018;52:23. doi: 10.11606/s1518-8787.2018052000293. Epub 2018 Feb 26.
9
Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.中等收入国家糖尿病流行状况变化的经济后果:以墨西哥为例。
Diabetes Care. 2004 Jan;27(1):104-9. doi: 10.2337/diacare.27.1.104.
10
[The cost of diabetes in Latin America: evidence from Mexico].[拉丁美洲糖尿病的成本:来自墨西哥的证据]
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S85-8. doi: 10.1016/j.jval.2011.05.022.

引用本文的文献

1
A global perspective on the costs of hypertension: a systematic review.高血压成本的全球视角:系统评价
Arch Med Sci. 2020 Jan 31;16(5):1078-1091. doi: 10.5114/aoms.2020.92689. eCollection 2020.
2
Attributable Burden and Expenditure of Cardiovascular Diseases and Associated Risk Factors in Mexico and other Selected Mega-Countries.墨西哥和其他选定的特大型国家心血管疾病及其相关危险因素的可归因负担和支出。
Int J Environ Res Public Health. 2019 Oct 22;16(20):4041. doi: 10.3390/ijerph16204041.
3
Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.墨西哥无医疗保险的慢性肾病患者的死亡率:国家肾脏健康政策的机遇
Kidney Int Rep. 2018 Jun 20;3(5):1171-1182. doi: 10.1016/j.ekir.2018.06.004. eCollection 2018 Sep.

本文引用的文献

1
Health Disparities in and Transdisciplinary Approach to Cardiovascular Disease in Mexico.墨西哥心血管疾病的健康差异及跨学科研究方法
Am J Public Health. 2015 Oct;105(10):e3-4. doi: 10.2105/AJPH.2015.302824. Epub 2015 Aug 13.
2
Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine.拉丁美洲的2型糖尿病与医疗保健成本:探讨加强预防医学的必要性。
BMC Med. 2014 Aug 19;12:136. doi: 10.1186/s12916-014-0136-z.
3
[Hypertension: prevalence, early diagnosis, control and trends in Mexican adults].[高血压:墨西哥成年人中的患病率、早期诊断、控制情况及趋势]
Salud Publica Mex. 2013;55 Suppl 2:S144-50.
4
Hypertension and its effects on the economy of the health system for patients and society: suggestions for developing countries.高血压及其对患者和社会卫生系统经济的影响:对发展中国家的建议
Am J Hypertens. 2014 Apr;27(4):635-6. doi: 10.1093/ajh/hpu010. Epub 2014 Mar 8.
5
Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.拉丁美洲高血压的流行病学变化与经济负担:来自墨西哥的证据
Am J Hypertens. 2006 Jun;19(6):553-9. doi: 10.1016/j.amjhyper.2005.10.028.
6
The cost of diabetes in Latin America and the Caribbean.拉丁美洲和加勒比地区糖尿病的成本。
Bull World Health Organ. 2003;81(1):19-27. Epub 2003 Mar 11.
7
[Cost of care of arterial hypertension and its impact on the budget assigned to health in Mexico].[动脉高血压的护理成本及其对墨西哥卫生预算的影响]
Salud Publica Mex. 2002 Jan-Feb;44(1):7-13.
8
The prevalence and treatment of hypertension in the elderly population of the Mexican Institute of Social Security.墨西哥社会保障机构老年人群中高血压的患病率及治疗情况
Salud Publica Mex. 2001 Sep-Oct;43(5):415-20. doi: 10.1590/s0036-36342001000500005.
9
The friction cost method for measuring indirect costs of disease.用于衡量疾病间接成本的摩擦成本法。
J Health Econ. 1995 Jun;14(2):171-89. doi: 10.1016/0167-6296(94)00044-5.